by Alicia Gailliez, Business Development Manager, One Nucleus
This year’s ON Helix conference at the Babraham Research Campus brought together biotech innovators, service providers, pharma leaders, investors, and academics in an interactive atmosphere to explore cutting-edge developments in tools, therapeutics, devices, and ecosystems that are shaping the future of translational research.
There are times when it can feel like a small world when chance meetings and connections are encountered. On the flip side, when a company is seeking the right investor, collaborator or client, then the world can seem awfully big without some guidance of where to look.
RESI Boston 2025, a key component of Biotech Week Boston, will take place on September 17 at the Westin Copley Place, followed by two days of virtual partnering on September 18-19. This hybrid format combines the benefits of in-person networking with the flexibility of online interactions. The Westin Copley Place, serving as the RESI venue, is strategically located just a 10-minute walk from the Hynes Convention and Exhibition Center, the main hub for Biotech Week Boston events.
By Monalisa Breazu, Learning & Development Administrator
July 28, 2025
Devens, MA, USA — Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, is pleased to announce the appointment of Thomas Rohrer as Vice President of Bioconjugation. This appointment follows a recently announced investment to establish cGMP bioconjugation capabilities at its Devens, MA site.
Expert in targeted protein degradation and drug discovery will support development of the Company’s portfolio of novel small molecule degraders
Biotechgate Digital Partnering is an online event that runs four times a year to support the business development & licensing of Pharma, Biotech, Medtech and Digital Health companies. Biotechgate Digital Partnering usually hosts over 1,000 representatives from leading life science companies and investors from around the globe, including big pharma, biotech start-ups and corporate investors.
The next edition of the popular five-day international conference series will be held virtually from August 25 to 25, 2025, and is free to attend.
The UK government has officially launched its landmark Life Sciences Sector Plan, backed by over £2 billion in public funding and spearheaded by the Department for Science, Innovation and Technology, Business and Trade, and Health and Social Care.
The ambitious ten-year roadmap forms a central pillar of the government’s wider Industrial Strategy and its 10 Year Health Plan, aiming to position the UK as Europe’s leading and the world’s third largest life sciences economy by 2035.
by Tony Jones, CEO, One Nucleus
By Philippa Clark, Director of Business Development, One Nucleus